ERBB2 and breast carcinoma: found that intraductal injection of retrovirus expressing activated versions of Ras or erbB2 into Sprague/Dawley rats led to ER+ tumors (122). This intraductal model has a defined genetic mutation and is more relevant to human breast cancer etiology than DMBA models.